{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:54:48Z","timestamp":1792205688666,"version":"4.4.0"},"reference-count":48,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T00:00:00Z","timestamp":1527897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The incidence of infectious diseases caused by several bacterial pathogens such as Haemophilus influenzae type b, Streptococcus pneumoniae, and Neisseria meningitidis, has been dramatically reduced over the last 25 years through the use of glycoconjugate vaccines. The structures of the bacterial capsular polysaccharide (CPS) antigens, extracted and purified from microbial cultures and obtained with very high purity, show that many of them are decorated by O-acetyl groups. While these groups are often considered important for the structural identity of the polysaccharides, they play a major role in the functional immune response to some vaccines such as meningococcal serogroup A and Salmonella typhi Vi, but do not seem to be important for many others, such as meningococcal serogroups C, W, Y, and type III Group B Streptococcus. This review discusses the O-acetylation status of CPSs and its role in the immunological responses of these antigens.<\/jats:p>","DOI":"10.3390\/molecules23061340","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T08:59:41Z","timestamp":1528102781000},"page":"1340","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Role of O-Acetylation in the Immunogenicity of Bacterial Polysaccharide Vaccines"],"prefix":"10.3390","volume":"23","author":[{"given":"Francesco","family":"Berti","sequence":"first","affiliation":[{"name":"Technical R&amp;D, GSK Vaccines, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"De Ricco","sequence":"additional","affiliation":[{"name":"Preclinical R&amp;D, GSK Vaccines, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[{"name":"External R&amp;D, GSK Vaccines, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,6,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1517\/14712598.2015.993375","article-title":"Glycoconjugate vaccines: An update","volume":"15","author":"Vella","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1517\/17460441.2011.609554","article-title":"The design of semi-synthetic and synthetic glycoconjugate vaccines","volume":"6","author":"Costantino","year":"2011","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jpba.2005.01.044","article-title":"NMR assays for carbohydrate-based vaccines","volume":"38","author":"Jones","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13996","DOI":"10.1074\/jbc.M112.346924","article-title":"Structural characterization of Streptococcus pneumoniae serotype 9A capsule polysaccharide reveals role of glycosyl 6-O-acetyltransferase wcjE in serotype 9V capsule biosynthesis and immunogenicity","volume":"287","author":"Calix","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1128\/JCM.02695-13","article-title":"Spectrum of pneumococcal serotype 11A variants results from incomplete loss of capsule O-acetylation","volume":"52","author":"Calix","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Camilli, R., Spencer, B.L., Moschioni, M., Pinto, V., Berti, F., Nahm, M.H., and Pantosti, A. (2014). Identification of Streptococcus pneumoniae serotype 11E, serovariant 11Av and mixed populations by high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and flow cytometric serotyping assay (FCSA). PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100722"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/S0001-37652005000200009","article-title":"Vaccines based on the cell surface carbohydrates of pathogenic bacteria","volume":"77","author":"Jones","year":"2005","journal-title":"An. Acad. Bras. Cienc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2958.2003.03819.x","article-title":"Genetics of capsule O-acetylation in serogroup C, W-135 and Y meningococci","volume":"51","author":"Claus","year":"2004","journal-title":"Mol. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0021-9258(19)42828-7","article-title":"Determination of the structure and conformation of bacterial polysaccharides by carbon 13 nuclear magnetic resonance. Studies on the group-specific antigens of Neisseria meningitidis serogroups A and X","volume":"249","author":"Bundle","year":"1974","journal-title":"J. Biol. Chem."},{"key":"ref_10","first-page":"1808","article-title":"Factors contributing to the immunogenicity of meningococcal conjugate vaccines","volume":"12","author":"Berti","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"42765","DOI":"10.1074\/jbc.M313552200","article-title":"The Neisseria meningitidis serogroup A capsular polysaccharide O-3 and O-4 acetyltransferase","volume":"279","author":"Gudlavalleti","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.vaccine.2008.01.022","article-title":"Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases","volume":"26","author":"Bardotti","year":"2008","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3201\/eid1904.111799","article-title":"Description and nomenclature of Neisseria meningitidis capsule locus","volume":"19","author":"Harrison","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"19395","DOI":"10.1074\/jbc.M114.575142","article-title":"Molecular cloning and functional characterization of components of the capsule biosynthesis complex of Neisseria meningitidis serogroup A: toward in vitro vaccine production","volume":"289","author":"Fiebig","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1128\/IAI.70.7.3707-3713.2002","article-title":"Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses","volume":"70","author":"Berry","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1128\/CVI.00162-13","article-title":"Meningococcal polysaccharide A O-acetylation levels do not impact the immunogenicity of the quadrivalent meningococcal tetanus toxoid conjugate vaccine: results from a randomized, controlled phase III study of healthy adults aged 18 to 25 years","volume":"20","author":"Lupisan","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_17","first-page":"151","article-title":"Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: Effect of O-acetylation on the nature of the protective epitope","volume":"103","author":"Michon","year":"2000","journal-title":"Dev. Biol. (Basel)"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1128\/iai.42.2.599-604.1983","article-title":"Reactivity and immunogenicity of bivalent (AC) and tetravalent (ACW135Y) meningococcal vaccines containing O-acetyl-negative or O-acetyl-positive group C polysaccharide","volume":"42","author":"Vodopija","year":"1983","journal-title":"Infect. Immun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1542\/peds.76.1.91","article-title":"Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides","volume":"76","author":"Peltola","year":"1985","journal-title":"Pediatrics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/infdis\/152.4.850","article-title":"Immunogenicity of O-acetyl-negative and -positive polysaccharide vaccines for infections with Neisseria meningitidis group C in infants","volume":"152","author":"Pichichero","year":"1985","journal-title":"J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/14760584.8.3.265","article-title":"Prevention of meningococcal serogroup C disease by NeisVac-C","volume":"8","author":"Borrow","year":"2009","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CVI.00009-07","article-title":"Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation","volume":"14","author":"Fusco","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1574-695X.2002.tb00543.x","article-title":"O-acetylation status of the capsular polysaccharides of serogroup Y and W135 meningococci isolated in the UK","volume":"32","author":"Longworth","year":"2002","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0140-6736(00)03502-9","article-title":"Serogroup W135 meningococcal disease in Hajj pilgrims","volume":"356","author":"Taha","year":"2000","journal-title":"Lancet"},{"key":"ref_25","first-page":"586","article-title":"Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharide","volume":"12","author":"Giardina","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7887","DOI":"10.1128\/IAI.73.12.7887-7893.2005","article-title":"Conjugates of group A and W135 capsular polysaccharides of Neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice","volume":"73","author":"Jin","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1016\/j.vaccine.2007.06.018","article-title":"Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide","volume":"46","author":"Gudlavalleti","year":"2007","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11123","DOI":"10.1073\/pnas.0403010101","article-title":"Discovery and characterization of sialic acid O-acetylation in group B Streptococcus","volume":"101","author":"Lewis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/BJ20100232","article-title":"O-acetylation of sialic acid on group B Streptococcus inhibits neutrophil suppression and virulence","volume":"428","author":"Weiman","year":"2010","journal-title":"Biochem. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jpba.2014.05.004","article-title":"Exploring the Group B Streptococcus capsular polysaccharides: the structural diversity provides the basis for development of NMR-based identity assays","volume":"98","author":"Pinto","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1016\/j.vaccine.2009.05.039","article-title":"Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation","volume":"27","author":"Pannaraj","year":"2009","journal-title":"Vaccine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1073\/pnas.1701885114","article-title":"Structure of a protective epitope of group B Streptococcus type III capsular polysaccharide","volume":"114","author":"Carboni","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1139\/o81-073","article-title":"The specific capsular polysaccharide of Streptococcus pneumoniae type 9V","volume":"59","author":"Perry","year":"1981","journal-title":"Can. J. Biochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1128\/IAI.66.8.3705-3710.1998","article-title":"Antibody responses to capsular polysaccharide backbone and O-acetate side groups of Streptococcus pneumoniae type 9V in humans and rhesus macaques","volume":"66","author":"McNeely","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0008-6215(84)85409-9","article-title":"Structural determination of the capsular polysaccharide of Streptococcus pneumoniae type 18C (56)","volume":"131","author":"Lugowski","year":"1984","journal-title":"Carbohydr. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1016\/j.vaccine.2012.09.047","article-title":"Relevance of O-acetyl and phosphoglycerol groups for the antigenicity of Streptococcus pneumoniae serotype 18C capsular polysaccharide","volume":"30","author":"Chang","year":"2012","journal-title":"Vaccine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1128\/jb.94.5.1406-1410.1967","article-title":"Physiochemical properties of the Vi antigen before and after mild alkaline hydrolysis","volume":"94","author":"Jarvis","year":"1967","journal-title":"J. Bacteriol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/iai.29.2.539-544.1980","article-title":"Immunochemical properties of Vi antigen from Salmonella typhi Ty2: Presence of two antigenic determinants","volume":"29","author":"Szewczyk","year":"1980","journal-title":"Infect. Immun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/iai.59.12.4555-4561.1991","article-title":"Relation between structure and immunologic properties of the Vi capsular polysaccharide","volume":"59","author":"Szu","year":"1991","journal-title":"Infect. Immun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.carres.2005.02.001","article-title":"Revised structures for the capsular polysaccharides from Staphylococcus aureus Types 5 and 8 components of novel glycoconjugate vaccines","volume":"340","author":"Jones","year":"2005","journal-title":"Carbohydr. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/21645515.2017.1386360","article-title":"O-acetylation is essential for functional antibody generation against Staphylococcus aureus capsular polysaccharide","volume":"14","author":"Scully","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa011297","article-title":"Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis","volume":"346","author":"Shinefield","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.vaccine.2003.11.034","article-title":"Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials","volume":"22","author":"Fattom","year":"2004","journal-title":"Vaccine"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4161\/hv.34414","article-title":"Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study","volume":"11","author":"Fattom","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9258(18)56740-5","article-title":"The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application","volume":"180","author":"Hestrin","year":"1949","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0731-7085(02)00462-4","article-title":"Use and validation of NMR assays for the identity and O-acetyl content of capsular polysaccharides from Neisseria meningitidis used in vaccine manufacture","volume":"30","author":"Jones","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/biol.1999.0238","article-title":"Use and validation of an NMR test for the identity and O-acetyl content of the Salmonella typhi Vi capsular polysaccharide vaccine","volume":"28","author":"Lemercinier","year":"2000","journal-title":"Biologicals"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.vaccine.2003.08.008","article-title":"Quantification of O-acetyl, N-acetyl and phosphate groups and determination of the extent of O-acetylation in bacterial vaccine polysaccharides by high-performance anion-exchange chromatography with conductivity detection (HPAEC-CD)","volume":"22","author":"Kao","year":"2004","journal-title":"Vaccine"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/23\/6\/1340\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:07:00Z","timestamp":1760195220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/23\/6\/1340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,2]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["molecules23061340"],"URL":"https:\/\/doi.org\/10.3390\/molecules23061340","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,2]]}}}